- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
In 2006, has the EHR's time finally come?
The editors at CMP Healthcare Media have been watching development of the electronic health record for several years, waiting for a time when all the stars might align-technology, infrastructure, and interest from providers. That time may be upon us. One quarter of healthcare executives polled by HIMSS claim to have a functioning medical record in place, and another 36% are plunging ahead with plans of their own.
The editors at CMP Healthcare Media have been watching development of the electronic health record for several years, waiting for a time when all the stars might align-technology, infrastructure, and interest from providers. That time may be upon us. One quarter of healthcare executives polled by HIMSS claim to have a functioning medical record in place, and another 36% are plunging ahead with plans of their own.
What exactly an EHR is may still be subject to debate, but standards for data sharing and integration are quickly breaking down barriers among departments and silos of information. As business editor Greg Freiherr notes in his article on page S-12, these standards should allow health entities to become more fully integrated, whether they rely on a single vendor platform or connect multiple systems. The result will expose radiology's output, and the specialty's value in the clinical process, more completely to the rest of the clinical team.
Look for Diagnostic Imaging to cover this evolution in practice in the months and years ahead, including the changes in standards and technology as well as the effect that an ever-growing volume of data has on the clinical care process.
-Jane Lowers is special projects editor for Diagnostic Imaging
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
